Stay updated on Pembrolizumab vs Paclitaxel in Asian Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Paclitaxel in Asian Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Paclitaxel in Asian Gastric Cancer Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.5.3 replaces the previous v3.5.2, signaling a site version update. It does not alter the study details or primary content of the page.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe revision label was updated from Revision: v3.5.0 to Revision: v3.5.2.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedThe site software version was updated from v3.4.3 to v3.5.0. No changes to study content or visible features are indicated.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. The change is limited to the page version tag and does not modify study details or content.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page now includes a new site revision tag: Revision: v3.4.2. The older funding-status notice and the earlier Revision: v3.4.1 text have been removed.SummaryDifference0.3%

- Check93 days agoChange DetectedAdded a government funding lapse notice regarding NIH site status and updated the site revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab vs Paclitaxel in Asian Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Paclitaxel in Asian Gastric Cancer Clinical Trial page.